ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 30 No. 2 | February 23, 2007

Download PDF Visit The Full Archive

Related Articles

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

National Coalition An Education Group, Chairman Says

May 3, 1985

Group Chairmen Criticize NCI Budget Priorities

July 11, 2003

White House Picks Harold Varmus For NCI

May 21, 2010

The March To Deliver Message Of Funding For Cancer Research, Access To Care

September 4, 1998

Chi Van Dang Named Director of University Of Pennsylvania Abramson Cancer Center

July 15, 2011